ARCHIVES

Also in this 8-page issue: Dept. of Justice, Congress to investigate Merck and FDA actions on Vioxx; FDA asks IOM to study its monitoring system for approved drugs.

This article is from The Cancer Letter archive.

Vol. 30 No. 43 | November 12, 2004

Download PDF Visit The Full Archive

Related Articles

Katterhagen Predicts Increase Support From State, Local sources, Sees It As Community Challenge

March 27, 1981

FDA Approves Lapatinib For Advanced Breast Cancer

March 30, 2007

Postdoc Fabricated Results In Published Study, ORI Says.

October 27, 2000

As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray

December 13, 2002

NCAB To Study Recommendations On Cooperative Groups, Coordination Of NCI Treatment Programs

June 20, 1975

NCI considers allowing some centers to opt out of site visits.

March 19, 2004